LIVE FROM THE DATABASETRANSACTIONS 723,671COMPANIES 6,572LATEST TRADE Oct 27UPDATED Oct 28, 12:45 PM
Reporting ownerCIK 0001737436

Kathryn J. Collier

14 transactions in one company, from April 30, 2025 to June 25, 2025.

Transactions
141 company
Bought · P
$0open market
Sold · S
$0open market
Net
+$0net buying

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
Regulus Therapeutics Inc.RGLS14——

All transactions

14 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValueHeld after
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirDERIVJun 25DReturned to issuer60,000——0derivatives
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirDERIVJun 25DReturned to issuer30,000——0derivatives
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirDERIVJun 25DReturned to issuer15,000——0derivatives
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirDERIVJun 25DReturned to issuer30,000——0derivatives
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirDERIVJun 25DReturned to issuer9,000——0derivatives
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirDERIVJun 25DReturned to issuer4,650——0derivatives
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirJun 25DReturned to issuer75,565——0
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirDERIVJun 17MOption exercise2,325$0.00—?0derivatives
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirDERIVJun 17MOption exercise2,604$0.00—?0derivatives
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirDERIVJun 16MOption exercise1,396$0.00—?2,604derivatives
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirJun 17MOption exercise2,325$8.80$20K62,915
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirJun 17MOption exercise2,604$9.90$26K65,240
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirJun 16MOption exercise1,396$9.90$14K67,844
Regulus Therapeutics Inc.RGLSKathryn J. CollierDirApr 30AAward62,500$0.00—69,240